Company: CMND
Filing Date: 2025-11-26
Form Type: F-1
Source: 0001213900-25-115501
Chunk: 19

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-26
Form: F-1
Chunk 19
---
 and the related notes, before you decide to buy our securities. The risks and uncertainties described below are not the only risks facing us. We may face additional risks and uncertainties not currently known to us or that we currently deem to be immaterial. Any of the risks described below, and any such additional risks, could materially adversely affect our business, financial condition or results of operations. In such case, you may lose all or part of your original investment.

The sale of a substantial amount of our ordinary shares, including resale of the ordinary shares issuable upon the exercise of the warrants held by the selling shareholders in the public market could adversely affect the prevailing market price of our ordinary shares.

We are registering for resale an aggregate of 5,781,250
common shares issuable upon the exercise of warrants held by the selling shareholders. Sales of substantial amounts of our common shares
in the public market, or the perception that such sales might occur, could adversely affect the market price of our common shares, and
the market value of our other securities. We cannot predict if and when selling shareholders may sell such shares in the public markets.
Furthermore, in the future, we may issue additional common shares or other equity or debt securities convertible into common shares. Any
such issuance could result in substantial dilution to our existing shareholders and could cause our share price to decline.

Part of our operations are conducted in Israel. Conditions in Israel, including the recent attack by Hamas and other terrorist organizations and Israel’s war against them, may affect our operations.

Our operations are located
in the State of Israel. In addition, certain of our key employees and officers, including our chief executive officer, are residents of
Israel. Accordingly, political, economic and military conditions in the Middle East may affect our business directly. Since the establishment
of the State of Israel in 1948, a number of armed conflicts have occurred between Israel and its neighboring countries and terrorist organizations
active in the region, including Hamas (an Islamist militia and political group in the Gaza Strip) and Hezbollah (an Islamist militia and
political group in Lebanon).

In October 2023, Hamas terrorists
infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas
also launched extensive rocket attacks on Israeli population and industrial centers located along Israel’s border with the Gaza
Strip and in other areas within the State of Israel. These attacks resulted in extensive deaths, injuries and kidnapping of civilians
and soldiers. Following the attack, Israel’s security